171![May 14, 2002 Dear Healthcare Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports May 14, 2002 Dear Healthcare Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports](https://www.pdfsearch.io/img/729be9b40724db83542088c3ac70b87b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
172![May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o](https://www.pdfsearch.io/img/20b70f8fc4a9264f45637ed245833518.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
173![Drug ABACAVIR ABACAVIR/LAMIVUDINE ABACAVIR/LAMIVUDINE/ZIDOVUDINE ABATACEPT Drug ABACAVIR ABACAVIR/LAMIVUDINE ABACAVIR/LAMIVUDINE/ZIDOVUDINE ABATACEPT](https://www.pdfsearch.io/img/b5e631f140f6f48c184f4789be5f28ba.jpg) | Add to Reading ListSource URL: www.ouhsc.eduLanguage: English - Date: 2014-06-18 12:56:08
|
---|
174![US Jemsek Dear HCP Letter FINAL DRAFT2.PDF US Jemsek Dear HCP Letter FINAL DRAFT2.PDF](https://www.pdfsearch.io/img/2a086ba9c8d84b3154b7bcf26105e366.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
175![July[removed]IMPORTANT DRUG WARNING RE: July[removed]IMPORTANT DRUG WARNING RE:](https://www.pdfsearch.io/img/9beef74c13de972540df723df8c5eabf.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
176![CDER Drug and Biologic Approvals for Calendar Year 2008 Updated through December 31, 2008 New Drug Application (NDA) Approvals: Application Type CDER Drug and Biologic Approvals for Calendar Year 2008 Updated through December 31, 2008 New Drug Application (NDA) Approvals: Application Type](https://www.pdfsearch.io/img/cfeaf26bb449a625227c64ff729b20ec.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
177![CDER Priority Drug and Biologic Approvals in Calendar Year 2011 CDER Priority Drug and Biologic Approvals in Calendar Year 2011](https://www.pdfsearch.io/img/b92b720bf52062a6d5524b3122c05545.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
178![Health / Antiretroviral drug / AIDS / HIV / Therapeutic drug monitoring / Viral load / Abacavir / Protease inhibitor / Reverse-transcriptase inhibitor / HIV/AIDS / Medicine / Pharmacology Health / Antiretroviral drug / AIDS / HIV / Therapeutic drug monitoring / Viral load / Abacavir / Protease inhibitor / Reverse-transcriptase inhibitor / HIV/AIDS / Medicine / Pharmacology](/pdf-icon.png) | Add to Reading ListSource URL: aidsinfonet.orgLanguage: English - Date: 2014-04-21 15:27:03
|
---|
179![AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 127 AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 127](https://www.pdfsearch.io/img/12dcc0e658ec243d6d302f30238ecb8d.jpg) | Add to Reading ListSource URL: aidsinfonet.orgLanguage: English - Date: 2014-04-21 15:27:03
|
---|
180![AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 127 AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 127](https://www.pdfsearch.io/img/e6c2ac6975cc3ec61c414dfe93a75915.jpg) | Add to Reading ListSource URL: www.aidsinfonet.orgLanguage: English - Date: 2014-04-21 15:27:03
|
---|